Aspen Aerogels, Inc. provided earnings guidance for the year 2022. The company expects, total revenue is expected to range between $145.0 million and $155.0 million, Net loss is expected to range between $66.7 million and $70.7 million and net loss per share is expected to range between $1.88 and $1.99.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.67 USD | +3.54% | +9.82% | +5.64% |
03-06 | Roth MKM Initiates Aspen Aerogels With Buy Rating, $22 Price Target | MT |
02-14 | B. Riley Lowers Price Target on Aspen Aerogels to $24 From $26, Says Upside Remains Compelling; Keeps Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.64% | 1.28B | |
+11.76% | 63.38B | |
-3.58% | 46.51B | |
+13.66% | 39.91B | |
+19.57% | 25.57B | |
+7.93% | 18.95B | |
+1.44% | 17.58B | |
-20.33% | 16.1B | |
+1.06% | 14.98B | |
-12.98% | 14.78B |
- Stock Market
- Equities
- ASPN Stock
- News Aspen Aerogels, Inc.
- Aspen Aerogels, Inc. Provides Earnings Guidance for the Year 2022